top of page
AdobeStock_1867238062.jpeg

Pricing & Reimbursement

We build localised value stories aligned with clinical practice, patient and payer priorities, providing end-to-end support from early access to reimbursement, including Belgium-specific budget impact modelling and hands-on negotiation of Managed Entry Agreements.

100%

Executional Excellence

120+

Successful Submissions

+25 yrs

Experience

3 Countries

BeNeLux

Market Access

Navigate complex regulatory landscapes with strategies tailored to local payer requirements.

Pricing & Reimbursement

Develop robust pricing models that reflect value while ensuring payer acceptance across different markets.

Launch Excellence

Orchestrate seamless product launches with integrated cross-functional plans and real-time performance tracking.

Patient & Payer Engagement

Facilitate meaningful dialogue with payers and HTA bodies to align expectations and secure favourable outcomes.

Integrated Market Access Solutions

We bridge the gap between clinical value and commercial success through rigorous analysis and strategic foresight.

Policy & Advocacy

Shape the healthcare environment by engaging key stakeholders and influencing policy decisions.

Health Economics (HEOR)

Generate compelling evidence and value dossiers to demonstrate cost-effectiveness and Clinical value.

Value Proposition

Crafting a compelling value story and gathering necessary clinical and economic evidence.

02

Landscape Assessment

An in-depth analysis of the current landscape, unmet needs, and payer perceptions.

01

Strategy Development

Defining the optimal pricing, contracting, and access strategy for each target market.

03

04

Execution & Launch

Following up on addressing clinical and budgetary uncertainties to maintain patient access.

Integrated Market Access Solutions

A systematic approach ensuring no critical milestone is overlooked, from early-stage development to post-launch optimisation.

Our Methodology

Axes Health at the Rare Diseases Forum 2026

Axes Health at the Rare Diseases Forum 2026: Innovation alone is not enough

Rare Diseases Forum 2026

Innovation in medicines does not stop with approval.

Innovation in medicines does not stop with approval.

Early access programmes make it possible to start an innovative treatment earlier in case of a clear medical need.

Strategic Insights

Latest thinking and analysis from our team of experts.

Why Choose Axes Health? 

Recognised executional excellence.

Deep respect for the patient's voice

Unmatched expertise in rare diseases.

Respected partner by health authorities.

Send us a message

Fill out the form below.

Get in Touch

Whether you have a question about our services, pricing, or need expert strategy consultation, our team is ready to answer all your questions.

Watt The Health, Kliniekstraat 27a

9050 Gent, Belgium

+32 475 75 26 46

Executional Excellence

Delivering high-quality solutions with precision and reliability

Data Driven

Leveraging Real World Data for impactful decision making.

Partnering for Better Health Access

We bridge the gap between innovation and patient access through strategic pricing, reimbursement expertise, and robust evidence generation.

ABOUT US

SERVICES

HOME

bottom of page